涂曦丰 助理教授 (Tu, Hsi-Feng)
個人簡歷
學歷
畢/肄業學校 主修系別學位 學位 畢業年度
國立陽明大學  臨床牙醫學研究所  碩士  2002
台北醫學大學  牙醫學系  學士  1998
經歷
服務單位 服務部門 職稱 服務期間起
陽明大學附設醫院  牙科部  副主任  2008/08/01- 
陽明大學附設醫院  牙科部  主治醫師  2008/01/01-2008/07/31 
台北榮民總醫院  口腔醫學部  特約醫師  2005/01/01-2008/12/31 
署立宜蘭醫院  牙科  主治醫師  2004/09/02-2007/12/31 
陽明大學  牙醫學系  兼任講師  2004/08/01-2008/7/31 
台北榮民總醫院  牙科部口腔顎面外科  住院醫師  2002/06/01-2004/9/1
台北榮民總醫院  牙科部口腔顎面外科  進修住院醫師  1998/100/1-2002/5/31 
現職:
國立陽明大學牙醫學系專任助理教授
國立陽明大學附設醫院牙科主任
專長:口腔顎面外科、口腔癌化機轉
聯絡電話:(03)9325192*1212
電子郵件hsifeng@gmail.com
研究方向

口腔癌表觀遺傳分析、口腔癌致病機轉

研究計畫(5年內)
年度 計畫名稱 計畫內擔任之工作 執行期間 經費提供單位
2010 RNA miR-31及p53調控基因p53RPF與口腔癌放射抗性之角色研究(2/2)  主持人  2010/08/01~2011/07/31  國科會 
2010 微型RNA-149多型性與口腔麟狀細胞癌之關係  主持人  2010/01/01~2010/12/31  陽明大學附設醫院 
2010 RNA miR-31及p53調控基因p53RPF與口腔癌放射抗性之角色研究(2/2)  主持人  2010/08/01~2011/07/31  國科會 
2009 探討血漿中腫瘤壞死因子第三號誘餌受體濃度與口腔癌病患預後之關係  主持人  2009/01/01~2010/12/31  陽明大學附設醫院 
2009 RNA miR-31及p53調控基因p53RPF與口腔癌放射抗性之角色研究(1/2)  主持人  2009/08/01~2010/07/31  國科會 
2008 發展以血漿中微型RNA含量做為口腔癌生物標記之研究  主持人  2008/10/20~2009/12/30  陽明大學附設醫院 

期刊論文(* 通訊作者)

1.

Liu, C. J., Kao, S. Y., Tu, H. F., Tsai, M. M., Chang, K. W., Lin, S. C.. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. ORAL DISEASES 2010;16(4):360-364 (SCI).(Impact factor: 2.087;Rank: 16.36%)

2.

Shieh TM, Chang KW, Tu HF, Shih YH, Ko SY, Chen YC, Liu CJ. Association between the polymorphisms in exon 12 of hypoxia-inducible factor-1α and the clinicopathological features of oral squamous cell carcinoma. ORAL ONCOLOGY 2010;46(9):e47-e53 (SCI).(Impact factor: 2.928;Rank: 9.09%)

3.

Chiu YW, Tu HF, Wang IK, Wu CH, Chang KW, Liu TY, Kao SY.. The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis. ORAL ONCOLOGY 2010;46(4):302-6 (SCI).(Impact factor: 2.928;Rank: 9.09%)

4.

Kao SY, Chen YP, Tu HF, Liu CJ, Yu AH, Wu CH, Chang KW. Nuclear STK15 expression is associated with aggressive behaviour of oral carcinoma cells in vivo and in vitro. JOURNAL OF PATHOLOGY 2010;222(1):99-109 (SCI).(Impact factor: 5.121;Rank: 8.70%)

5.

Tu HF, Liu CJ, Liu SY, Chen YP, Yu EH, Lin SC, Chang KW. Serum decoy receptor 3 level: A predictive marker for nodal metastasis and survival among oral cavity cancer patients. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 2010;: (SCI).(Impact factor: 2.603;Rank: 3.23%)

6.

Liu HS, Lu HH, Lui MT, Yu EH, Shen W, Chen YP, Chang KW, Tu HF. Detection of copy number amplification of cyclin D1 (CCND1) and cortactin (CTTN) in oral carcinoma and oral brushed samples from areca chewers. ORAL ONCOLOGY 2009;45(12):1032-6 (SCI).(Impact factor: 2.928;Rank: 9.09%)

7.

Wu CH, Tu HF, Gong NR, Chen YW, Liu CJ, Kao SY. The Val allele of HER-2 codon 655 predicts the progression of oral squamous cell carcinoma. ORAL ONCOLOGY 2009;45(7):579-583 (SCI).(Impact factor: 2.928;Rank: 9.09%)

8.

Shieh TM, Tu HF, Ku TH, Chang SS, Chang KW, Liu CJ. Association between lysyl oxidase polymorphisms and oral submucous fibrosis in older male areca chewers. JOURNAL OF ORAL PATHOLOGY & MEDICINE 2009;38(1):109-113 (SCI).(Impact factor: 1.63;Rank: 43.64%)

9.

Hung PS, Kao SY, Liu CJ, Tu HF, Wu CH, Lin SC. Insulin-like growth factor binding protein-5 enhances the migration and differentiation of gingival epithelial cells. JOURNAL OF PERIODONTAL RESEARCH 2008;43(6):673-80 (SCI).(Impact factor: 2.038;Rank: 20.00%)

10.

Tu HF, Chen HW, Kao SY, Lin SC, Liu CJ, Chang KW. MDM2 SNP 309 and p53 codon 72 polymorphisms are associated with the outcome of oral carcinoma patients receiving postoperative irradiation. RADIOTHERAPY AND ONCOLOGY 2008;87(2):243-52 (SCI).(Impact factor: 3.99;Rank: 13.04%)

11.

Chen, Y. W. Tu, H. F. Wu, T. H. Lo, W. L. Chang, C. S. Chang, K. W. Kao, S. Y.. Sarcomas and sarcomatoid tumor after radiotherapy of oral squamous cell carcinoma: analysis of 4 cases. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS 2008;105(1):65-71 (SCI).(Impact factor: 1.581;Rank: 47.27%)

12.

Kao SY, Fong JH, Chou SJ, Wu JH, Tu HF, Yeung TC. Segmental osteotomy to reposition multiple osseointegrated dental implants in the anterior maxilla in a trauma patient. DENTAL TRAUMATOLOGY 2007;23(1):56-9 (SSCI).(Impact factor: 1.274;Rank: 60.00%)

13.

Tu HF, Wu CH, Kao SY, Liu CJ, Liu TY, Lui MT. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users. JOURNAL OF ORAL PATHOLOGY & MEDICINE 2007;9((7):409-14 (SCI).(Impact factor: 1.63;Rank: 43.64%)

14.

Tu, H. F. Liu, C. J. Chang, C. S. Lui, M. T. Kao, S. Y. Chang, C. P. Liu, T. Y.. The functional (-1171 5A-->6A) polymorphisms of matrix metalloproteinase 3 gene as a risk factor for oral submucous fibrosis among male areca users. JOURNAL OF ORAL PATHOLOGY & MEDICINE 2006;35(2):99-103 (SCI).(Impact factor: 1.63;Rank: 43.64%)

15.

Kao SY, Tu HF, Chang KW, Chang CS, Yang AH, Li WY. Epithelioid sarcoma metastasis to the gingivae: a case report. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY 2004;33(2):205-8 (SCI).(Impact factor: 1.487;Rank: 45.27%)

16.

Kao, S. Y. Tu, H. F. Chang, K. W. Chang, C. S. Yang, C. C. Lin, S. C.. The retinoic acid receptor-beta (RAR-beta) mRNA expression in the oral squamous cell carcinoma associated with betel quid use. JOURNAL OF ORAL PATHOLOGY & MEDICINE 2002;31(4):220-6 (SCI).(Impact factor: 1.63;Rank: 43.64%)

17.

Kao SY, Tu H, Chang RC, Yang AH, Chang KW, Lee CH. Primary ectopic thyroid papillary carcinoma in the floor of the mouth and tongue: a case report. BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY 2002;40(3):213-5 (SCI).(Impact factor: 0.787;Rank: 72.30%)

     

得獎紀錄
  1.2006/03/12:參加中華民國口腔顎面外科學會九十五年度第十八次學術研討會發表口頭論文報告,經評選為最佳論文,得獎論文題目:口腔鱗狀上皮細胞癌細胞核內類胰島素生長因子結合蛋白-5之表現與功能
2.獲得國立陽明大學經費補助研究生出席國際會議,赴香港參加亞洲地區口腔顎面外科學會第七屆學術研討會(ACOMS) (2006/11/05 –2006/11/09) ,發表口頭論文報告:The role of MDM2 polymorphism in areca-related oral squamous cell carcinoma,獲補助二萬元



 

回頁首